机构:[1]Department of Pathology, The Fourth Hospital of Hebei Medical University/Hebei Tumor Hospital, Hebei province, Shijiazhuang, China.医技科室病理科河北医科大学第四医院[2]Department of Gastrointestinal Surgery, The Fourth Hospital of Hebei Medical University/Hebei Tumor Hospital, Hebei province, Shijiazhuang, China.河北医科大学第四医院[3]Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University/Hebei Tumor Hospital, Hebei province, Shijiazhuang, China. jiaowenpeng163@163.com.河北医科大学第四医院
第一作者机构:[1]Department of Pathology, The Fourth Hospital of Hebei Medical University/Hebei Tumor Hospital, Hebei province, Shijiazhuang, China.
推荐引用方式(GB/T 7714):
Liu Yao,Liu Yu,Jiao Wen-Peng.Correction to: MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway[J].BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE.2023,174(5):699-699.doi:10.1007/s10517-023-05773-7.
APA:
Liu Yao,Liu Yu&Jiao Wen-Peng.(2023).Correction to: MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway.BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE,174,(5)
MLA:
Liu Yao,et al."Correction to: MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway".BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 174..5(2023):699-699